Neuroinflammation, Stem Cells, and Stroke.

Neuroinflammation, Stem Cells, and Stroke.
复制标题

DOI:
10.1161/strokeaha.121.036948
复制
发表时间:
2022-05
期刊:
影响因子:
8.3
通讯作者:
--
中科院分区:
医学1区
文献类型:
--
作者:

文献摘要

参考文献

被引文献

相似文献

Stroke remains a significant unmet clinical need with few treatment options that have a very narrow therapeutic window, thereby causing massive mortality and morbidity in the US and around the world. Accordingly, finding safe and effective novel treatments with a wider therapeutic window stands as an urgent need in stroke. The progressive inflammation that occurs centrally and peripherally after stroke serves as a unique therapeutic target to retard and even halt the secondary cell death. Stem cell therapy represents a potent approach that can diminish inflammation in both the stroke brain and periphery (e.g., spleen), advancing a paradigm-shift from a traditionally brain-focused therapy to treating stroke as a neurological disorder with a significant peripheral pathology. The purpose of this review paper is to highlight the inflammation- mediated secondary cell death that plagues both brain and spleen in stroke and to evaluate the therapeutic potential of stem cell therapy in dampening these inflammatory responses.
DOI: 10.1371/journal.pone.0026821
发表时间: 2011
期刊: PloS one
影响因子: 3.7
作者:
Lai Y;Asthana A;Cheng K;Kisaalita WS
通讯作者: Kisaalita WS
DOI: 10.1007/s12015-021-10222-x
发表时间: 2021-12
影响因子: 4.8
作者:
Borlongan MC;Farooq J;Sadanandan N;Wang ZJ;Cozene B;Lee JY;Steinberg GK
通讯作者: Steinberg GK